financetom
Business
financetom
/
Business
/
EU probes on Chinese subsidies and imports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EU probes on Chinese subsidies and imports
May 5, 2024 7:53 AM

(Reuters) -The European Union launched an investigation into China's procurement of medical devices on Wednesday in a latest effort to protect home-grown manufacturers.

It has also launched several probes into whether Chinese clean tech producers are dumping subsidised goods on its market and whether Chinese-owned companies unfairly benefit from subsidies while operating inside the EU.

The European Commission, which is carrying out the investigations, says its aim is to prevent unfair competition and market distortion.

Here's what you need to know about the investigations:

MEDICAL DEVICES

The European Commission launched a probe into Chinese public procurement of medical devices, the EU's official journal said on April 24.

The investigation is the first under the EU International Procurement Instrument, which aims to prevent countries from unfairly favouring domestic suppliers.

If the Commission finds that European suppliers don't have fair access to the Chinese market, it could place restrictions on Chinese medical device companies bidding in EU public tenders.

The investigation is to be concluded within nine months, although the Commission can extend this period by a further five months.

WIND TURBINES

The EU is investigating subsidies received by Chinese suppliers of wind turbines destined for Europe, the bloc's anti-trust commissioner Margrethe Vestager said on April 9.

It will look into wind park development in Spain, Greece, France, Romania and Bulgaria, Vestager said without naming specific companies.

China said the probe was "discriminatory" against Chinese enterprises and endorsed protectionism.

SOLAR PANELS

The Commission opened two investigations under the EU Foreign Subsidies Regulation (FSR) into whether two Chinese bidders benefited excessively from subsidies in their offers in a public tender for a solar power park in Romania, it said on April 3.

The investigations concern a consortium composed of Romania's ENEVO and a unit of China's LONGi, and subsidiaries of Chinese state-owned Shanghai Electric Group.

The Commission has until Aug. 14 to take a decision on whether to block the contract, accept commitments from the companies to eliminate the distortion of competition, or not to object.

The Commission's first investigation launched under the FSR, concerning a Chinese train maker's participation in a Bulgarian tender for electric trains, ended after CRRC Qingdao Sifang Locomotive withdrew its tender.

ELECTRIC VEHICLES

The Commission said on Sept. 13 it would launch an anti-subsidy investigation into Chinese electric vehicles to determine whether to impose punitive tariffs on them.

It wants to find out if Chinese exports of EVs to the EU market are benefitting from excessive subsidies.

China's commerce minister Wang Wentao said in April that U.S. and European assertions of excess Chinese EV capacity were baseless, while a Chinese industry body said the probe was stacked against Chinese manufacturers.

The investigation, officially launched on Oct. 4, will last up to 13 months. The Commission can impose provisional anti-subsidy duties nine months after the start of the probe.

(Compiled by Chiara Holzhaeuser, Agnieszka Olenska and Philippe Leroy Beaulieu; Edited by Milla Nissi and Mark Potter)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With CNS Pharmaceuticals Stock Tuesday?
What's Going On With CNS Pharmaceuticals Stock Tuesday?
Jul 30, 2024
CNS Pharmaceuticals, Inc. ( CNSP ) shares traded higher initially Tuesday morning but have since reversed following the company’s announcement that it entered into an exclusive license agreement with Cortice Biosciences. The Details: CNS secured an exclusive license and the intellectual property rights for TPI 287, a potential treatment for glioblastoma multiforme (GBM). CNS will pay Cortice 616, 698 shares...
Update: Secure Energy Services Rises 7% as Q2 Earnings Miss Estimates, But Raises its Adjusted EBITDA Guidance
Update: Secure Energy Services Rises 7% as Q2 Earnings Miss Estimates, But Raises its Adjusted EBITDA Guidance
Jul 30, 2024
12:17 PM EDT, 07/30/2024 (MT Newswires) -- Secure Energy Services ( SECYF ) on Tuesday reported second-quarter earnings that missed forecasts, but raised its full-year 2024 adjusted EBITDA guidance. The oilfield waste-management company said it earned $32 million, or $0.12 per share, in the quarter, down from $34 million, or $0.11, in the year-prior quarter, missing the consensus estimate for...
Airbus second-quarter profit falls on jetliner ramp-up costs and space charge
Airbus second-quarter profit falls on jetliner ramp-up costs and space charge
Jul 30, 2024
(Corrects profit to 814 million euros, not 813 million, in 2nd paragraph, and adjusts currency conversion) PARIS (Reuters) - Europe's Airbus reported sharply lower second-quarter profits on Tuesday as the cost of investing in higher jetliner production, coupled with largely pre-announced charges in its Space Systems business, outweighed higher revenue. The world's largest planemaker said adjusted operating profit fell by...
Hershey Q2 Organic Growth Could Miss Market Views, RBC Says
Hershey Q2 Organic Growth Could Miss Market Views, RBC Says
Jul 30, 2024
12:17 PM EDT, 07/30/2024 (MT Newswires) -- Hershey's (HSY) Q2 organic growth could fall short of market expectations amid downside in North America confection, though its salty snacks business is likely to outperform expectations, RBC Capital Markets said in a note e-mailed Tuesday. The confectionery company is scheduled to report Q2 results Thursday. RBC expects earnings of $1.48 per share,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved